Skip to main content
Clinical Trials/ACTRN12607000131459
ACTRN12607000131459
Recruiting
Phase 4

A randomised controlled trial of the effect of high flow versus titrated oxygen therapy on carbon dioxide (CO2) levels in acute severe asthma

Medical Research Institute of New Zealand0 sites150 target enrollmentFebruary 15, 2007

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Acute asthma
Sponsor
Medical Research Institute of New Zealand
Enrollment
150
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 15, 2007
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • History of asthma; Presentation to the emergency department with an acute exacerbation of asthma; Forced expiratory volume in 1 second (FEV1\) less than or equal to 50% predicted

Exclusion Criteria

  • Diagnosis of Chronic obstructive pulmonary disease (COPD)/emphysema; Asthma attack requiring mechanical ventilation; Patient unconscious, unable to speak or unable to perform spirometry on arrival; Known or suspected chronic hypercapnic respiratory failure as a result of any of the following disorders \- neuromuscular disease, chest wall disease, obesity hypoventilation syndrome.

Outcomes

Primary Outcomes

Not specified

Similar Trials